Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.57 USD | +6.08% | +4.68% | +52.34% |
03-19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
03-15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- KROS Stock
- Revisions Keros Therapeutics, Inc.